Pharmacological effects of acute and repeated administration of Δ9-tetrahydrocannabinol in adolescent and adult rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 3, 2007, Pages 1097-1105

  Wiley, Jenny L ^a   O'Connell, Mary M ^a   Tokarz, Mary E ^a   Wright Jr , M Jerry ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRONABINOL;

ADOLESCENT; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXPOSURE; FEMALE; HYPOTHERMIA; LOCOMOTION; MALE; NONHUMAN; PERINATAL PERIOD; PREDICTION; PRIORITY JOURNAL; RAT; REPEAT PROCEDURE;

AGING; ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; PSYCHOTROPIC DRUGS; RATS; RATS, LONG-EVANS; SEX FACTORS; TETRAHYDROCANNABINOL;

EID: 33847129301     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.108126     Document Type: Article

References (36)

1. Bass CE and Martin BR (2000) Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice. Drug Alcohol Depend 60:113-119.
2. Belue RC, Howlett AC, Westlake TM, and Hutchings DE (1995) The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol Teratol 17:25-30.
3. Berrendero F, García-Gil L, Hernández ML, Romero J, Cebeira M, de Miguel R, Ramos JA, and Fernández-Ruiz JJ (1998) Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development 125:3179-3188.
4. Berrendero F, Sepe N, Ramos JA, Di Marzo V, and Fernández-Ruiz JJ (1999) Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 33:181-191.
5. 9-tetrahydrocannabinol in male and female rats. Res Commun Chem Pathol Pharmacol 5:621-626.
6. Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Vogt LJ, and Sim-Selley LJ (1999) Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem 73:2447-2459.
7. Breivogel CS, Sim LJ, and Childers SR (1997) Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Pharmacol Exp Ther 282:1632-1642.
8. Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR, and Martin BR (1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265:218-226.
9. De Vry J, Jentzsch KR, Kuhl E, and Eckel G (2004) Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development. Behav Pharmacol 15:1-12.
10. Ehrenreich H, Rinn T, Kunert HJ, Moeller MR, Poser W, Schilling L, Gigerenzer G, and Hoehe MR (1999) Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology 142:295-301.
11. Fan F, Compton DR, Ward S, Melvin L, and Martin BR (1994) Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212. J Pharmacol Exp Ther 271:1383-1390.
12. 9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat. Synapse 45:134-142.
13. Kenakin T (1993) Efficacy, in Pharmacologic Analysis of Drug-Receptor Interaction (Kenakin T ed) pp 249-277, Raven Press Ltd., New York.
14. Lichtman AH and Martin BR (2005) Cannabinoid tolerance and dependence. Handb Exp Pharmacol 168:691-717.
15. Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, and Ward SJ (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 40:471-478.
16. Mato S, Del Olmo E, and Pazos A (2003) Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci 17:1747-1754.
17. McLaughlin CR, Martin BR, Compton DR, and Abood ME (1994) Cannabinoid receptors in developing rats: detection of mRNA and receptor binding. Drug Alcohol Depend 36:27-31.
18. Nasello AG, Sassatani AS, Ferreira FS, Felicio LF, and Tieppo CA (2003) Modulation by sudden darkness of apomorphine-induced behavioral responses. Physiol Behav 78:521-528.
19. National Research Council (1996) Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC.
20. Rodríguez de Fonseca F, Cebeira M, Ramos JA, Martin M, and Fernandez-Ruiz JJ (1994) Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sci 54:159-170.
21. Rodr?́guez de Fonseca F, Ramos JA, Bonnin A, and Fernández-Ruiz JJ (1993) Presence of cannabinoid binding sites in the brain from early postnatal ages. Neuroreport 4:135-138.
22. Romero EM, Fernández B, Sagredo O, Gomez N, Urigüen L, Guaza C, De Miguel R, Ramos JA, and Viveros MP (2002) Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats. Dev Brain Res 136:85-92.
23. Romero J, Garcia-Palomero E, Berrendero F, Garcia-Gil L, Hernandez ML, Ramos JA, and Fernandez-Ruiz JJ (1997) Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse 26:317-323.
24. 9-tetrahydrocannabinol. Synapse 30:298-308.
25. Selley DE, Rorrer WK, Breivogel CS, Zimmer AM, Zimmer A, Martin BR, and Sim-Selley LJ (2001) Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation. J Neurochem 77:1048-1057.
26. 35S]thio]-triphosphate binding. Proc Natl Acad Sci USA 92:7242-7246.
27. 9-tetrahydrocannabinol on cannabinoid receptor adaptation in mice. J Pharmacol Exp Ther 303:36-44.
28. Spear LP (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463.
29. Tallarida RJ and Murray RB (1987) Manual of Pharmcologic Calculations with Computer Programs, 2nd ed. Springer-Verlag New York Inc., New York.
30. Tseng AH and Craft RM (2001) Sex differences in antinociceptive and motoric effects of cannabinoids. Eur J Pharmacol 430:41-47.
31. 9-tetrahydrocannabinol-induced behavioral effects in rats. Behav Brain Res 154:77-83.
32. 9-tetrahydrocannabinol administration in the rat. Psychopharmacology 161:129-136.
33. 9-tetrahydrocannabinol in the rat. Drug Alcohol Depend 71:169-177.
34. 9- tetrahydrocannabinol on locomotor activity in mice. Neurosci Lett 352:77-80.
35. Wiley JL and Martin BR (2003) Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol 471:185-193.
36. 9-tetrahydrocannabinol and anandamide analogs in mice. Eur J Pharmacol 510:59-68.